Newsroom

Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023

PDF Version MENLO PARK, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...

read more +
Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023

PDF Version The event will include presentations from leading glaucoma surgeons and remarks from the Sight Sciences executive management team MENLO PARK, Calif., April 13, 2023 (GLOBE NEWSWIRE) —  Sight...

read more +
Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer

PDF Version Ali Bauerlein Ali Bauerlein has been appointed Sight Sciences’ Chief Financial Officer and Treasurer, effective April 3, 2023 MENLO PARK, Calif., April 03, 2023 (GLOBE NEWSWIRE) — Sight...

read more +
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office

PDF Version MENLO PARK, Calif., March 30, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions...

read more +
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results

PDF Version MENLO PARK, Calif., March 13, 2023 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on creating innovative solutions...

read more +
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System

PDF Version Ergo-Series of the OMNI® Surgical System by Sight Sciences, Inc. The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma...

read more +
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference

Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference   PDF Version   MENLO PARK, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) — Sight...

read more +
Sight Sciences Announces 1,000th TearCare® Customer Installation

PDF Version Over 1,000 Professional Eye Care Practices Have integrated the TearCare® System to Treat Root Cause of Dry Eye Disease due to Meibomian Gland Dysfunction (MGD) MENLO PARK, Calif., Jan....

read more +